| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $3,517,477 ) |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS119517 | Novel Modulators of TGFß1 signaling in regulation of remyelination by neural stem cells | 000 | 5 | NIH | 12/5/2025 | $335,675 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM128620 | Biosensor-driven Platforms for Biosynthesis of Natural Products in Bacteria | 000 | 8 | NIH | 12/22/2025 | $353,810 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM157138 | Characterizing the regulation of cell envelope biosynthesis in Pseudomonas aeruginosa | 000 | 2 | NIH | 12/12/2025 | $325,168 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM148433 | O-glycosylation of cysteine-rich modules | 000 | 4 | NIH | 12/15/2025 | $394,110 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI182884 | Maternal vaccination impacts on neonatal susceptibility and response to Bordetella pertussis | 000 | 2 | NIH | 12/4/2025 | $181,080 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R61AI187112 | Establishing strains and conditions for long-term P. vivax cultures | 000 | 2 | NIH | 12/3/2025 | $379,960 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01ES036241 | Novel Epitranscriptomic Mechanisms in Metal Neurotoxicity | 000 | 2 | NIH | 12/17/2025 | $448,960 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01ES034196 | Role of Prokineticin 2 in Metal Neurotoxicity | 000 | 4 | NIH | 12/22/2025 | $349,842 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI173144 | Impacts of host lipid composition on antimicrobial susceptibilities of Staphylococcus aureus | 000 | 4 | NIH | 12/8/2025 | $477,462 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG076625 | Implications of Metabolic Dysfunction during Thiamine Insufficiency | 000 | 4 | NIH | 12/10/2025 | $331,600 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31DK141239 | A process evaluation of a pragmatic randomized controlled trial to promote mental health among adults with Type 1 diabetes | 000 | 2 | NIH | 12/19/2025 | $43,828 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | NU58DP007332 | Healthier Together: High Obesity Program in Georgia | 01 | 3 | CDC | 12/15/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | NU58DP007332 | Healthier Together: High Obesity Program in Georgia | 01 | 3 | CDC | 12/15/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | U01AG074960 | Novel Reengineered Microbiome-based Biologic Therapy to Treat Cognitive and Behavioral Symptoms of Alzheimer's Disease and Related Dementias | 000 | 4 | NIH | 12/11/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM139656 | Unlocking sequence-structure-function-disease relationships in large protein super-families | 000 | 5 | NIH | 12/9/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21HL168507 | A deep learning-enhanced multiphysics and multiscale framework for predictive modeling of inflammation-induced thrombosis | 000 | 2 | NIH | 11/11/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI175925 | Development of ganglioside specific IgGs for the treatment of Guillian-Barré Syndrome | 000 | 2 | NIH | 11/13/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL134899 | Engineering nitric oxide releasing polymer with immobilized thrombin inhibitor for blood contacting applications | 000 | 8 | NIH | 10/8/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DK138306 | Advancing Targeted Therapies for Cushing's Disease Using Pituitary Neuroendocrine Tumor Organoids | 000 | 1 | NIH | 12/12/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | DP2AI154416 | Tapeworm stem cells as drivers of regeneration and reproduction | 000 | 5 | NIH | 12/9/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | T32AI060546 | Training in Tropical and Emerging Global Diseases | 000 | 20 | NIH | 11/19/2025 | -$96,195 |
| | 2026 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | T03OH012806 | Translating the Fisherman First Aid and Safety Training (FFAST) for Commercial Fishermen in the Southeastern United States | 02 | 1 | CDC | 11/13/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI171944 | Extracellular vesicles encapsulating CRISPR machinery for treatment of SARS-CoV-2 infection | 000 | 2 | NIH | 12/1/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01CA260698 | Developing LG007 as a novel therapeutic agent to treat triple negative breast cancer | 000 | 4 | NIH | 12/17/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01CA257851 | Development of a novel biodegradable inorganic nanoparticle therapeutic for cancer | 000 | 4 | NIH | 11/21/2025 | $0 |
| | 2026 | 2023 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AR080330 | Discover the Boosters of Myoblast Fusion | 000 | 2 | NIH | 12/15/2025 | $0 |
| | 2026 | 2023 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21NS128750 | Screening using split fluorescent protein tags for neurotransmitter receptors that define a synaptic balance in neuralcircuits | 000 | 1 | NIH | 12/2/2025 | $0 |
| | 2026 | 2023 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI171787 | Targeted delivery of antifungal drug loaded liposomes to control mucormycosis | 000 | 2 | NIH | 12/17/2025 | -$7,799 |
| | 2026 | 2023 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI141648 | Evaluation of pregnancy on vaccine-induced immunity and protection in a pre-clinical model of RSV infection | 000 | 4 | NIH | 12/15/2025 | $0 |
| | 2026 | 2022 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R00ES030015 | Role of Aflatoxin-induced DNA Damage Formation and Repair in Hepatic Mutagenesis | 000 | 4 | NIH | 12/5/2025 | $0 |
| | 2026 | 2022 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AA025911 | Using Neuroeconomics to Understand Alcohol Overvaluation in Alcohol Use Disorder | 000 | 5 | NIH | 12/5/2025 | -$24 |
|
| Issue Date FY: 2025 ( Subtotal = $65,751,269 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM150797 | Bacterial partners as a mode of fungal resistance to antimicrobial compounds | 000 | 3 | NIH | 5/7/2025 | $368,444 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL172496 | Nitric Oxide Functionalized Antibiotics to Combat Infections and Thrombosis for Extracorporeal Life Support | 000 | 2 | NIH | 1/28/2025 | $440,366 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21HD112848 | Uterine epithelial ERα regulates preimplantation uterine immunity and sperm fitness | 000 | 2 | NIH | 5/30/2025 | $188,750 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI176776 | Synthesis and transport of outer membrane components across the Gram-negative cell envelope | 000 | 3 | NIH | 12/23/2024 | $640,850 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R33MH121560 | Cognitive Training for Emotion Regulation in Psychotic Disorders | 000 | 4 | NIH | 8/5/2025 | $549,411 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI173144 | Impacts of host lipid composition on antimicrobial susceptibilities of Staphylococcus aureus | 000 | 3 | NIH | 11/4/2024 | $471,568 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21LM014569 | AI-MedWise: Developing and validating an artificial intelligence solution for effective video-based monitoring of medication adherence | 001 | 2 | NIH | 7/31/2025 | $169,875 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL173931 | Metabolic control of human endothelial development via the COUP-TF/1-deoxysphingosine axis | 001 | 2 | NIH | 7/1/2025 | $56,810 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL173931 | Metabolic control of human endothelial development via the COUP-TF/1-deoxysphingosine axis | 000 | 2 | NIH | 3/28/2025 | $511,305 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI180920 | Comparative transcriptomics of Plasmodium vivax strains to understand hypnozoite formation | 000 | 2 | NIH | 4/30/2025 | $188,750 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AA026362 | The Neurokinin-1 Receptor as a Mediator of Alcoholism and Depression Comorbidity | 002 | 7 | NIH | 8/26/2025 | $340,623 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AT012783 | Multi-omics approaches to lower the barriers to sustainable production of plant natural products with relevance to human health | 000 | 2 | NIH | 12/6/2024 | $485,272 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM152057 | Regulation of protein transport in cilia | 002 | 2 | NIH | 8/14/2025 | $54,481 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM152057 | Regulation of protein transport in cilia | 001 | 2 | NIH | 11/13/2024 | $490,327 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | K01AR082421 | Steps Towards OA Prevention | 000 | 3 | NIH | 7/10/2025 | $121,473 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI185250 | Roles of C. albicans white-opaque regulators in biofilm and virulence | 000 | 2 | NIH | 5/13/2025 | $195,312 |
| | 2025 | 2025 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HD114750 | Mechanisms of uterine fluid absorption during early pregnancy | 000 | 2 | NIH | 4/4/2025 | $648,318 |
|
